PARSIPPANY, N.J., Jan. 15, 2018 /PRNewswire/ — Castle Creek Pharmaceuticals (CCP), a global biotech company dedicated to delivering transformative therapies to patients with orphan dermatologic and other underserved conditions, today announced that data from an evaluation of a completed…
